Davipharm is a trusted brand and one of the leading domestic manufacturers of high-quality generic drugs in Ho Chi Minh City. With European standards and WHO-GMP certification, Davipharm has been committed to providing affordable and reliable medicinal products since its establishment in 2004. Over the years, Davipharm has expanded its operations and achieved significant milestones.

In 2014, they started exporting their medicinal products to the Philippines and Cambodia and became one of the top 5 local pharmaceutical companies in 2016. In 2017, Davipharm was acquired by Adamed Pharma S. A., the biggest direct Polish investor in Vietnam, to enhance production standards and technology transfers.

In 2021, Davipharm opened Vietnam's first certified HP Zone for the production of cytotoxic/cytostatic oral solids, and later that same year, they obtained EU-GMP certification for non-sterile products in capsules, hard shells, and tablets. Looking ahead, Davipharm aims to achieve EU-GMP certification for other production lines, such as soft capsules, sachets, and creams, by 2025. With a focus on R&D excellence, new product launches, and contract manufacturing, Davipharm is dedicated to strengthening its position in the domestic market and becoming the SE Asia export hub